Royce & Associates’s Inspire Medical Systems INSP Stock Holding History

Royce & Associates’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-42,269	Closed	-$8.6M	–	903
2023 Q4	$8.6M	Buy	42,269 +28,781	+213%	+$4.66M	0.08%	357
2023 Q3	$2.68M	Sell	13,488 -3,000	-18%	-$757K	0.03%	607
2023 Q2	$5.35M	Hold	16,488	–	–	0.05%	479
2023 Q1	$3.86M	Buy	16,488 +4,000	+32%	+$1.01M	0.04%	546
2022 Q4	$3.15M	Sell	12,488 -8,000	-39%	-$1.71M	0.03%	573
2022 Q3	$3.63M	Sell	20,488 -10,000	-33%	-$2.01M	0.04%	520
2022 Q2	$5.57M	Buy	30,488 +10,000	+49%	+$1.99M	0.06%	441
2022 Q1	$5.26M	Buy	20,488 +16,000	+357%	+$3.66M	0.04%	534
2021 Q4	$1.03M	Buy	+4,488	New	+$1.1M	0.01%	803

Other funds holding INSP

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Royce & Associates's INSP Position: Q1 2024 in Review

Royce & Associates sold out of Inspire Medical Systems (INSP) in Q1 2024, closing a stake of 42,269 shares — an estimated $8.6M sold.

Royce & Associates first reported a position in INSP in Q4 2021 and held it in 9 quarters. The position peaked at $8.6M in Q4 2023. 328 funds tracked by Wall St. Rank hold INSP as of Q1 2024.

Royce & Associates reported no remaining Inspire Medical Systems position as of Q1 2024 after selling out during the quarter.
Royce & Associates sold 42,269 Inspire Medical Systems shares in Q1 2024, an estimated $8.6M.
Royce & Associates first reported a position in Inspire Medical Systems in Q4 2021 and held it in 9 quarters.
Royce & Associates's Inspire Medical Systems position peaked at $8.6M in Q4 2023.
328 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2024.

Based on Royce & Associates's 13F filing for Q1 2024, filed 13 May 2024.